Register for free and gain unlimited access to our extensive elearning library
Earn CME points and track your learning activity with hundreds of hours of continuing medical education.
Bookmark and Share

Coming of age for CDK 4/6 inhibitors

These sessions took place during ESMO 2016 at the ecancer 'Coming of Age for CDK 4/6 Inhibitors' symposium.

Experts update on the latest data and expert opinion on all aspects of CDK 4/6 inhibition.

Supported by a grant from Pfizer Inc.

Coming of age for CDK 4/6 inhibitors
0 CME Points